Entrada Therapeutics Inc (TRDA)

CapEx to Revenue

6.89%

TTM · Retrieved:

TRDA logo

TRDA CapEx to Revenue

Current (TTM)6.89%
TRDA CapEx/Revenue (0.00% → 6.89%)
High-resolution chart · PNG

TRDA capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Entrada Therapeutics Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
4.095%
1.4982%
4.3515%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.